A
Anne-Sophie Rebillat
Publications - 22
Citations - 334
Anne-Sophie Rebillat is an academic researcher. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 6, co-authored 14 publications receiving 150 citations.
Papers
More filters
Journal ArticleDOI
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.
Andre Strydom,Antonia M. W. Coppus,Rafael Blesa,Adrian Danek,Juan Fortea,John Hardy,Johannes Levin,Georg Nuebling,Anne-Sophie Rebillat,Craig W. Ritchie,Cornelia M. van Duijn,Shahid Zaman,Henrik Zetterberg +12 more
TL;DR: Primary and secondary prevention trials for AD in DS are discussed and the potential barriers and solutions to such trials are described and the Europe‐wide Horizon21 Consortium to establish a DS‐AD prevention clinical trials network is described.
Journal ArticleDOI
Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings
Sandra Giménez,Laura Videla,Sergio Romero,Bessy Benejam,Susana Clos,Susana Fernández,Maribel Martínez,Maria Carmona-Iragui,Rosa M. Antonijoan,Mercedes Mayos,Ana María Fortuna,Patricia Peñacoba,Vicente Plaza,Ricardo S. Osorio,Ram A. Sharma,Ignasi Bardés,Anne-Sophie Rebillat,Alberto Lleó,Rafael Blesa,Sebastián Videla,Juan Fortea +20 more
TL;DR: In this paper, the prevalence of sleep disorders in adults with Down syndrome through self-reported and clinical data was found to be high in the presence of sleep apnea in adults.
Journal ArticleDOI
Acute Regression in Young People with Down Syndrome.
Clotilde Mircher,Cécile Cieuta-Walti,Isabelle Marey,Anne-Sophie Rebillat,Laura Cretu,Eliane Milenko,Martine Conte,Franck Sturtz,Marie-Odile Rethore,Aimé Ravel +9 more
TL;DR: A retrospective cohort study of regression cases of Down syndrome patients, finding 30 patients aged 11 to 30 years old with history of regression, which found girls were more frequently affected than boys.
Journal ArticleDOI
Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study.
Maria Carmona-Iragui,Daniel Alcolea,Isabel Barroeta,Laura Videla,Laia Muñoz,Kathyrn L Van Pelt,Frederick A. Schmitt,Donita Lightner,Lisa M. Koehl,Gregory A. Jicha,Silvia Sacco,Clotilde Mircher,Sarah E Pape,Rosalyn Hithersay,Isabel C. H. Clare,Isabel C. H. Clare,Anthony J. Holland,Georg Nübling,Johannes Levin,Shahid Zaman,Shahid Zaman,Andre Strydom,Anne-Sophie Rebillat,Elizabeth Head,Rafael Blesa,Alberto Lleó,Juan Fortea +26 more
TL;DR: In this article, the clinical utility of plasma neurofilament light chain (NfL) for the diagnosis of symptomatic Alzheimer's disease in Down syndrome, assess its prognostic value, and establish longitudinal changes in adults with Down syndrome.
Journal ArticleDOI
Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins.
Yuchen Gu,Gautier Moroy,Jean-Louis Paul,Anne-Sophie Rebillat,Mara Dierssen,Rafael de la Torre,Cécile Cieuta-Walti,Julien Dairou,Nathalie Janel +8 more
TL;DR: It is demonstrated that EGCG had well crossed the blood-brain barrier and was a noncompetitive inhibitor against ATP, molecular docking computations confirming these results.